140D0426C0122
Definitive Contract
Overview
Government Description
ARPA-H Snc Shield STTR Phase II
Awardee
Awarding Agency
Funding Agency
Place of Performance
Evanston, IL 60201 United States
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Research Type
Small Business Innovation Research Program (SBIR) Phase II
Est. Average FTE
8
Related Opportunity
None
SNC Therapeutics was awarded
Definitive Contract 140D0426C0122 (140D04-26-C-0122)
for Arpa-H Snc Shield Sttr Phase Ii
worth up to $3,498,387
by the National Institutes of Health
in September 2026.
The contract
has a duration of 2 years and
was awarded
with a Small Business Total set aside
with
NAICS 541713 and
PSC AN13
via direct negotiation acquisition procedures with 2 bids received.
Status
(Open)
Last Modified 9/28/26
Period of Performance
9/24/26
Start Date
9/27/28
Current End Date
9/27/28
Potential End Date
Obligations
$3.5M
Total Obligated
$3.5M
Current Award
$3.5M
Potential Award
Award Hierarchy
Definitive Contract
140D0426C0122
Subcontracts
Activity Timeline
People
Suggested agency contacts for 140D0426C0122
Competition
Number of Bidders
2
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
YNQPL17KGWA6
Awardee CAGE
253M3
Agency Detail
Awarding Office
140D04 IBC ACQ SVCS DIRECTORATE (00004)
Funding Office
75N992
Created By
jkunkle
Last Modified By
jgom10
Approved By
jgom10
Legislative
Legislative Mandates
None Applicable
Performance District
IL-09
Senators
Richard Durbin
Tammy Duckworth
Tammy Duckworth
Representative
Janice Schakowsky
Modified: 9/28/26